AMLODIPINE GH amlodipine 10 mg (as besilate) tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

amlodipine gh amlodipine 10 mg (as besilate) tablet blister pack

generic health pty ltd - amlodipine besilate, quantity: 13.867 mg (equivalent: amlodipine, qty 10 mg) - tablet, uncoated - excipient ingredients: mannitol; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate - hypertension: amlodipine gh tablets are indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoreceptor blocking agent or an angiotensin-converting enzyme inhibitor. angina: amlodipine gh tablets are indicated for the first line treatment of chronic stable angina. amlodipine gh tablets may be used alone, as monotherapy or in combination with other antianginal drugs.

AMLODIPINE GH amlodipine 5 mg (as besilate) tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

amlodipine gh amlodipine 5 mg (as besilate) tablet blister pack

generic health pty ltd - amlodipine besilate, quantity: 6.9335 mg (equivalent: amlodipine, qty 5 mg) - tablet, uncoated - excipient ingredients: mannitol; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate - hypertension: amlodipine gh tablets are indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoreceptor blocking agent or an angiotensin-converting enzyme inhibitor. angina: amlodipine gh tablets are indicated for the first line treatment of chronic stable angina. amlodipine gh tablets may be used alone, as monotherapy or in combination with other antianginal drugs.

APO-NICORANDIL nicorandil 10 mg tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

apo-nicorandil nicorandil 10 mg tablet blister pack

arrotex pharmaceuticals pty ltd - nicorandil, quantity: 10 mg - tablet, uncoated - excipient ingredients: povidone; cetyl alcohol; croscarmellose sodium; sodium stearylfumarate; mannitol - nicorandil is indicated for the treatment of chronic stable angina pectoris.

APO-NICORANDIL nicorandil 20 mg tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

apo-nicorandil nicorandil 20 mg tablet blister pack

arrotex pharmaceuticals pty ltd - nicorandil, quantity: 20 mg - tablet, uncoated - excipient ingredients: croscarmellose sodium; mannitol; povidone; cetyl alcohol; sodium stearylfumarate - nicorandil is indicated for the treatment of chronic stable angina pectoris.

IKOREL Nicorandil 20mg tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

ikorel nicorandil 20mg tablet blister pack

sanofi-aventis australia pty ltd - nicorandil, quantity: 20 mg - tablet, uncoated - excipient ingredients: maize starch; stearic acid; mannitol; croscarmellose sodium - ikorel is indicated for the treatment of chronic stable angina pectoris.

IKOREL Nicorandil 10mg tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

ikorel nicorandil 10mg tablet blister pack

sanofi-aventis australia pty ltd - nicorandil, quantity: 10 mg - tablet, uncoated - excipient ingredients: mannitol; maize starch; croscarmellose sodium; stearic acid - ikorel is indicated for the treatment of chronic stable angina pectoris.

PEXSIG perhexiline maleate 100mg tablet bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

pexsig perhexiline maleate 100mg tablet bottle

aspen pharma pty ltd - perhexiline maleate, quantity: 100 mg - tablet, uncoated - excipient ingredients: maize starch; purified talc; sucrose; lactose monohydrate - to reduce the frequency of moderate to severe attacks of angina pectoris due to coronary artery disease in patients who have not responded to other conventional therapy or in whom such therapy may be contra-indicated. note: because of the serious nature of potential side effects, perhexiline maleate should be reserved for use in patients with intractable angina who are refactory or intolerant to other agents and who are not suitable canditates for coronary bypass surgery.

DILTIAZEM AN diltiazem hydrochloride 60mg tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

diltiazem an diltiazem hydrochloride 60mg tablet blister pack

arrotex pharmaceuticals pty ltd - diltiazem hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hydrogenated castor oil; aluminium hydroxide; methacrylic acid copolymer; purified talc; magnesium stearate; titanium dioxide; indigo carmine; methylcellulose; macrogol 400 - moderate to severe angina pectoris due to atherosclerotic coronary artery disease or coronary artery spasm (vasospastic angina).

Atenolol-AFT atenolol 50 mg/10 mL oral solution bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

atenolol-aft atenolol 50 mg/10 ml oral solution bottle

aft pharmaceuticals pty ltd - atenolol, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: propylene glycol; propyl hydroxybenzoate; saccharin sodium; purified water; citric acid monohydrate; sorbitol solution (70 per cent) (non-crystallising); sodium citrate dihydrate; methyl hydroxybenzoate; flavour - all grades of hypertension including hypertension of renal origin.,frequent disabling angina without evidence of cardiac failure,cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those with acute myocardial infarction),myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)